acetylcysteine has been researched along with Psychotic Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, MF; Hellemann, G; Lee, J; Maddock, RJ; Marder, SR; Yang, YS; Zhang, H | 1 |
| Allott, K; Amminger, GP; Bartholomeusz, CF; Berk, M; Bortolasci, CC; Burnside, A; Chanen, A; Cotton, SM; Dean, OM; Dodd, S; McGorry, PD; O'Donoghue, B; Ratheesh, A; Uren, J; Walder, K; Watson, A; Wood, S | 1 |
| Barreiros, AR; Berk, M; Castle, DJ; Dean, OM; Hanratty, D; Hansen, A; Harris, AW; Neill, E; Phillipou, A; Rossell, SL; Siskind, D; Tan, EJ; Yolland, CO | 1 |
| Cabungcal, JH; Cleusix, M; Conus, P; Cuénod, M; Do, KQ; Dwir, D; Giangreco, B; Jenni, R; Klauser, P; Parietti, E; Steullet, P; Xin, L | 1 |
| Alameda, L; Baumann, PS; Clarke, S; Conus, P; Do, KQ; Ferrari, C; Fournier, M; Geiser, E; Jenni, R; Knebel, JF; Murray, MM; Retsa, C | 1 |
| Alameda, L; Baumann, PS; Buclin, T; Cleusix, M; Conus, P; Cousins, A; Cuenod, M; Do, KQ; Eap, CB; Ferrari, C; Fournier, M; Gholam-Rezaee, M; Golay, P; Gruetter, R; Jenni, R; Keshavan, MS; Seidman, LJ; Wojcik, J; Woo, TW; Xin, L | 1 |
| Koola, MM | 1 |
| Hellmich, M; Hurlemann, R; Kloss, C; Klosterkötter, J; Maier, W; Meyer-Lindenberg, A; Muthesius-Digón, A; Pantel, T; Ruhrmann, S; Schmidt, SJ; Schultz, J; Wasserthal, S; Wiesner, PS | 1 |
| Alemàn-Gómez, Y; Baumann, PS; Cleusix, M; Conus, P; Do, KQ; Griffa, A; Gruetter, R; Hagmann, P; Jenni, R; Klauser, P; Mullier, E; Roine, T; Xin, L | 1 |
| Miyake, N; Miyamoto, S; Ninomiya, Y; Tenjin, T; Yamaguchi, N; Yamashita, Y | 1 |
| Berk, M; Bush, AI; Dean, OM; Dodd, S; Malhi, GS; On, ZX; Rapado-Castro, M; Skvarc, DR | 1 |
| MacSweeney, JE; Mathieson, PW; Williams, G | 1 |
1 review(s) available for acetylcysteine and Psychotic Disorders
| Article | Year |
|---|---|
Meta-analysis of randomised controlled trials with
Topics: Acetylcysteine; Cognition; Humans; Memory, Short-Term; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia | 2020 |
6 trial(s) available for acetylcysteine and Psychotic Disorders
| Article | Year |
|---|---|
N-Acetylcysteine effects on glutathione and glutamate in schizophrenia: A preliminary MRS study.
Topics: Acetylcysteine; Glutamic Acid; Glutathione; Humans; Psychotic Disorders; Schizophrenia | 2022 |
ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis.
Topics: Acetylcysteine; Adolescent; Adult; Humans; Outcome Assessment, Health Care; Psychotic Disorders; Quality of Life; Randomized Controlled Trials as Topic; Young Adult | 2019 |
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
Topics: Acetylcysteine; Adolescent; Adult; Antioxidants; Biomarkers; Cognitive Dysfunction; Double-Blind Method; Female; Glutathione; Glutathione Peroxidase; Humans; Magnetic Resonance Spectroscopy; Male; Outcome Assessment, Health Care; Oxidation-Reduction; Prefrontal Cortex; Psychotic Disorders; Schizophrenia; Young Adult | 2018 |
Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.
Topics: Acetylcysteine; Adolescent; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Psychotic Disorders; Randomized Controlled Trials as Topic; Single-Blind Method; Stress, Psychological; Young Adult | 2019 |
N-Acetyl-Cysteine Supplementation Improves Functional Connectivity Within the Cingulate Cortex in Early Psychosis: A Pilot Study.
Topics: Acetylcysteine; Adult; Antioxidants; Brain Mapping; Dietary Supplements; Double-Blind Method; Europe; Female; Glutathione; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Oxidative Stress; Pilot Projects; Psychotic Disorders; Time Factors; Treatment Outcome; Young Adult | 2019 |
Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
Topics: Acetylcysteine; Adult; Attention; Bipolar Disorder; Cognitive Dysfunction; Executive Function; Female; Free Radical Scavengers; Humans; Male; Memory, Short-Term; Middle Aged; Psychotic Disorders; Schizophrenia; Treatment Outcome | 2017 |
5 other study(ies) available for acetylcysteine and Psychotic Disorders
| Article | Year |
|---|---|
Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psychosis.
Topics: Acetylcysteine; Adult; Animals; Combined Modality Therapy; Disease Models, Animal; Exercise Therapy; Female; Glutamate-Cysteine Ligase; Humans; Interneurons; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Parvalbumins; Psychotic Disorders; Receptor for Advanced Glycation End Products; Signal Transduction; Translational Research, Biomedical | 2021 |
Treatment in early psychosis with N-acetyl-cysteine for 6months improves low-level auditory processing: Pilot study.
Topics: Acetylcysteine; Acoustic Stimulation; Adult; Antipsychotic Agents; Contingent Negative Variation; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Follow-Up Studies; Humans; Male; Pilot Projects; Psychotic Disorders; Young Adult | 2018 |
Can N‑acetylcysteine, varenicline, or the combination prevent psychosis by enhancing mismatch negativity?
Topics: Acetylcysteine; Contingent Negative Variation; Drug Combinations; Humans; Psychotic Disorders; Risk Factors; Varenicline | 2019 |
Effects of N-Acetylcysteine on Cognitive Functions in Subjects With an At-Risk Mental State: A Case Series.
Topics: Acetylcysteine; Adolescent; Adult; Cognition; Female; Free Radical Scavengers; Humans; Male; Psychotic Disorders; Risk; Young Adult | 2016 |
Survival after massive ingestion of carbon tetrachloride treated by intravenous infusion of acetylcysteine.
Topics: Acetylcysteine; Aspartate Aminotransferases; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Humans; Infusions, Parenteral; Male; Middle Aged; Osteitis Deformans; Prothrombin; Psychotic Disorders; Radiography; Suicide, Attempted | 1985 |